Table 3.
Evolution of biological parameters and BMD in patient 2
| -36 months | -24 months | -12 months | Bone biopsy | +3 months | |
|---|---|---|---|---|---|
| CTX (250–4500 pmol/L) |
13700 |
ND |
4760 |
3650 |
6545 |
| Intact PTH (10–65 pg/mL) |
127 |
ND |
111 |
51 |
59 |
| 25-(OH) D (20–90 nmol/L) |
22 |
40 |
60 |
62 |
82 |
| Bone Alkaline |
|
|
|
|
|
| Phosphatase (11.6-30.6 U/L) |
21 |
7 |
9 |
10 |
11 |
| BMD (T-score) |
|
|
|
|
|
| Lumbar |
-2.6 |
ND |
ND |
-3.3 |
ND |
| Femoral neck | -3.1 | -3.5 |
CTX: Carboxy-terminal collagen crosslinks; PTH: Parathyroid hormone; BMD: Bone mineral density, ND: not determined.